Pneumococcal Surface Proteins as Virulence Factors, Immunogens, and Conserved Vaccine Targets
- PMID: 35646747
- PMCID: PMC9133333
- DOI: 10.3389/fcimb.2022.832254
Pneumococcal Surface Proteins as Virulence Factors, Immunogens, and Conserved Vaccine Targets
Abstract
Streptococcus pneumoniae is an opportunistic pathogen that causes over 1 million deaths annually despite the availability of several multivalent pneumococcal conjugate vaccines (PCVs). Due to the limitations surrounding PCVs along with an evolutionary rise in antibiotic-resistant and unencapsulated strains, conserved immunogenic proteins as vaccine targets continue to be an important field of study for pneumococcal disease prevention. In this review, we provide an overview of multiple classes of conserved surface proteins that have been studied for their contribution to pneumococcal virulence. Furthermore, we discuss the immune responses observed in response to these proteins and their promise as vaccine targets.
Keywords: CbpA; PhtD pneumococcal histidine triad protein D; PspA; PsrP; Streptoccoccus pneumoniae; conjugate vaccine; pneumococcal protein vaccine; pneumolysin (PLY).
Copyright © 2022 Aceil and Avci.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Fusion of PspA to detoxified pneumolysin enhances pneumococcal vaccine coverage.PLoS One. 2023 Dec 14;18(12):e0291203. doi: 10.1371/journal.pone.0291203. eCollection 2023. PLoS One. 2023. PMID: 38096222 Free PMC article.
-
Pneumococcal surface proteins as targets for next-generation vaccines: Addressing the challenges of serotype variation.Diagn Microbiol Infect Dis. 2025 Sep;113(1):116870. doi: 10.1016/j.diagmicrobio.2025.116870. Epub 2025 Apr 28. Diagn Microbiol Infect Dis. 2025. PMID: 40347702 Review.
-
Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children.Hum Vaccin Immunother. 2015;11(2):489-97. doi: 10.4161/21645515.2014.990861. Hum Vaccin Immunother. 2015. PMID: 25692218 Free PMC article.
-
[Proteins of Streptococcus pneumoniae: perspectives for development of pneumococcal vaccine].Zh Mikrobiol Epidemiol Immunobiol. 2010 Nov-Dec;(6):98-104. Zh Mikrobiol Epidemiol Immunobiol. 2010. PMID: 21384595 Review. Russian.
-
Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infants.Vaccine. 2019 May 1;37(19):2586-2599. doi: 10.1016/j.vaccine.2019.03.033. Epub 2019 Apr 8. Vaccine. 2019. PMID: 30975570 Clinical Trial.
Cited by
-
In silico design of an epitope-based vaccine against PspC in Streptococcus pneumoniae using reverse vaccinology.J Genet Eng Biotechnol. 2023 Dec 12;21(1):166. doi: 10.1186/s43141-023-00604-8. J Genet Eng Biotechnol. 2023. PMID: 38085389 Free PMC article.
-
In-silico design and evaluation of an epitope-based serotype-independent promising vaccine candidate for highly cross-reactive regions of pneumococcal surface protein A.J Transl Med. 2023 Jan 10;21(1):13. doi: 10.1186/s12967-022-03864-z. J Transl Med. 2023. PMID: 36627666 Free PMC article.
-
Recent progress in pneumococcal protein vaccines.Front Immunol. 2023 Sep 25;14:1278346. doi: 10.3389/fimmu.2023.1278346. eCollection 2023. Front Immunol. 2023. PMID: 37818378 Free PMC article. Review.
-
Fusion of PspA to detoxified pneumolysin enhances pneumococcal vaccine coverage.PLoS One. 2023 Dec 14;18(12):e0291203. doi: 10.1371/journal.pone.0291203. eCollection 2023. PLoS One. 2023. PMID: 38096222 Free PMC article.
-
Immune interface interference vaccines: An evolution-informed approach to anti-bacterial vaccine design.Microb Biotechnol. 2024 Mar;17(3):e14446. doi: 10.1111/1751-7915.14446. Microb Biotechnol. 2024. PMID: 38536702 Free PMC article.
References
-
- Alexander J. E., Lock R. A., Peeters C. C., Poolman J. T., Andrew P. W., Mitchell T. J., et al. . (1994). Immunization of Mice With Pneumolysin Toxoid Confers a Significant Degree of Protection Against at Least Nine Serotypes of Streptococcus Pneumoniae. Infect. Immun. 62, 5683–5688. doi: 10.1128/iai.62.12.5683-5688.1994 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases